(123)I-mIBG imaging predicts functional improvement and clinical outcome in patients with heart failure and CRT implantation

Antonio Curcio; Giuseppe Lucio Cascini; Salvatore De Rosa; Eugenia Pasceri; Claudia Veneziano; Stefania Cipullo; Milena Saccomanno; Giuseppe Santarpia; Giovanni Cuda; Ciro Indolfi

doi:10.1016/j.ijcard.2016.01.131

(123)I-mIBG imaging predicts functional improvement and clinical outcome in patients with heart failure and CRT implantation

Int J Cardiol. 2016 Mar 15:207:107-9. doi: 10.1016/j.ijcard.2016.01.131. Epub 2016 Jan 9.

Affiliations

¹ Division of Cardiology, Department of Medical and Surgical Sciences, University Magna Graecia, Catanzaro, Italy.
² Division of Nuclear Medicine, Department of Experimental and Clinical Medicine, University Magna Graecia, Catanzaro, Italy.
³ Laboratory of Clinical Biochemistry and Molecular Biology, Department of Experimental and Clinical Medicine, University Magna Graecia, Catanzaro, Italy.
⁴ Division of Cardiology, Department of Medical and Surgical Sciences, University Magna Graecia, Catanzaro, Italy; U.R.T.-C.N.R., Catanzaro, Italy. Electronic address: [email protected].

PMID: 26797344
DOI: 10.1016/j.ijcard.2016.01.131

No abstract available

Keywords: (123)I-metaiodobenzylguanidine (mIBG); Adrenergic nervous system; Cardiac resynchronization therapy (CRT); Echocardiography; Heart failure (HF); Myocardial imaging.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

3-Iodobenzylguanidine*
Aged
Cardiac Resynchronization Therapy / methods*
Electrocardiography / methods
Female
Heart Failure / diagnostic imaging*
Heart Failure / physiopathology
Heart Failure / therapy*
Humans
Male
Middle Aged
Predictive Value of Tests
Treatment Outcome

Substances

3-Iodobenzylguanidine